Erez Israeli, Dr. Reddy’s Laboratories CEO

An­oth­er In­di­an drug man­u­fac­tur­er hit with a Form 483 over re­cent ob­ser­va­tions

Sev­er­al In­di­an drug man­u­fac­tur­ers have been put un­der a mi­cro­scope by the FDA, as ma­jor gener­ics man­u­fac­tur­ers have been hit in re­cent months by Form 483s. And now Dr. Red­dy’s Lab­o­ra­to­ries is the lat­est to get the slap.

Ac­cord­ing to the In­di­an busi­ness news site Busi­ness Stan­dard, Dr. Red­dy’s Lab­o­ra­to­ries was served a Form 483. The form high­light­ed two ob­ser­va­tions af­ter in­spect­ing its man­u­fac­tur­ing fa­cil­i­ty lo­cat­ed at Srikaku­lam, In­dia, a city in the east.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.